期刊
CLINICAL & TRANSLATIONAL ONCOLOGY
卷 22, 期 1, 页码 60-69出版社
SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1007/s12094-019-02131-w
关键词
Microbubble; Ultrasound; Paclitaxel; MicroRNA-34a; Uterine cervical
类别
资金
- Medical College of Three Gorges University, Hubei Key Laboratory of the Tumor Microenvironment and Immunotherapy Foundation of China [2016KZL09, 2015KZL05, 2016PY052]
Purpose Improved therapeutic options for cervical cancer are needed. The purpose of this study was to evaluate the synergetic, inhibitory effects of ultrasound-mediated paclitaxel (PTX)- and miR- 34a-loaded microbubbles (MBs) on cervical cancer. Methods U14 cervical cancer cells and xenograft mouse tumors were treated with PTX-miR-34a-MBs. Results Levels of miR-34a increased in vitro and vivo after treatment with ultrasound-mediated PTX-miR-34a-MBs. Furthermore, this treatment decreased the proliferation of cervical cancer cells, microvessel density, and the expression of Bcl-2 and CDK6, both in vitro and in vivo. Furthermore, Bax expression was increased in the in vivo model. And, tumor volume and weight were significantly reduced by 78.57% and 87.97%, respectively (P < 0.01). Conclusions These results indicate that ultrasound-mediated PTX-miR-34a-MBs synergistically inhibit the growth of cervical cancer via the upregulation of miR-34a and downregulation of Bcl-2 and CDK6. Thus, PTX-miR-34a-MBs in combination with ultrasound microbubbles are a promising anticancer delivery strategy for treating cervical cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据